Skip to Main Content

Paper Details

Diabetic ketoacidosis in patients with type 2 diabetes treated with sodium glucose co-transporter 2 inhibitors versus other antihyperglycemic agents: An observational study of four US administrative claims databases.
Pharmacoepidemiol Drug Saf
28
2019
DKA, DPP, Diabetic ketoacidosis, GLP-1 receptor, Patients, SGLT2i, T2DM, diabetes, diabetic ketoacidosis, glucose, insulin, metformin, patients, secondary, sodium, sodium glucose, sodium glucose co-transporter 2, sulfonylureas, thiazolidinediones, type 1 diabetes, type 2 diabetes, type 2 diabetes mellitus

Datasets

Release 1.2